Juan A. Bueren‐Calabuig

Author

Also Known As

Juan A Bueren-Calabuig, Juan A. Bueren-Calabuig, Juan A. Bueren‐Calabuig, Juan Antonio Bueren-Calabuig, Juan Bueren-Calabuig, Juan A. Bueren-Calabuig

Publications

780

Citations

H-Index

Concepts

All Affiliations

University of Dundee Universidad de Alcalá Wellcome Centre for Anti-Infectives Research PharmaMar (Spain)GlaxoSmithKline (Spain)

About

Juan A. Bueren‐Calabuig is an author at University of Dundee specializing in molecular biology, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	10	10	296
2	Medicine	8	8	319
3	Biochemistry	6	6	112
4	Biomolecular Engineering	3	3	136
5	Engineering	2	2	32

Juan A. Bueren‐Calabuig

Publications

759

Citations

H-Index

Page 1

	Year	Citations
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition Susan Wyllie, Stephen Brand, Michael G. Thomas, Proceedings of the National Academy of Sciences	2019	165
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis Beatriz Baragaña, Barbara Forte, Ryan Choi, Proceedings of the National Academy of Sciences	2019	132
Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM Dhaval Varshney, Alain‐Pierre Petit, Juan A. Bueren‐Calabuig, Nucleic Acids Research Protein AssemblyMolecular RegulationMolecular BiologyEpigeneticsNucleic Acid Chemistry	2016	80
Molecular pharmacology and antitumor activity of Zalypsis® in several human cancer cell lines Juan Fernando Martínez-Leal, Verónica García-Hernández, Victoria Moneo, Biochemical Pharmacology Molecular PharmacologyMedicinal ChemistryAntitumor ActivityChemoprevention StrategyMedicine	2009	68
Temperature-induced melting of double-stranded DNA in the absence and presence of covalently bonded antitumour drugs: insight from molecular dynamics simulations Juan A. Bueren‐Calabuig, Christophe Giraudon, Carlos M. Galmarini, Nucleic Acids Research	2011	65
XPF-Dependent DNA Breaks and RNA Polymerase II Arrest Induced by Antitumor DNA Interstrand Crosslinking-Mimetic Alkaloids Sascha Feuerhahn, Christophe Giraudon, Marta Martínez, Chemistry & Biology Tumor BiologyMedicinal ChemistryXpf-dependent Dna BreaksOncogenic AgentMedicine	2011	48
Mechanism of allosteric activation of human mRNA cap methyltransferase (RNMT) by RAM: insights from accelerated molecular dynamics simulations Juan A. Bueren‐Calabuig, Marcus Bage, Victoria H. Cowling, Nucleic Acids Research Rnmt ActivityMolecular BiologyAllosteric ActivationProtein SynthesisTranscriptional Regulation	2019	35
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i> Richard J. Wall, Sandra Carvalho, Rachel Milne, ACS Infectious Diseases	2020	33
Elucidation of Ligand-Dependent Modulation of Disorder-Order Transitions in the Oncoprotein MDM2 Juan A. Bueren‐Calabuig, Julien Michel PLoS Computational Biology Mdm2 Lid RegionProtein AssemblyBiomolecular Structure PredictionMolecular BiologyMolecular Dynamics	2015	31
Impact of Ser17 Phosphorylation on the Conformational Dynamics of the Oncoprotein MDM2 Juan A. Bueren‐Calabuig, Julien Michel Biochemistry Conformational DynamicsProtein AssemblyBiomolecular Structure PredictionSer17 PhosphorylationMolecular Biology	2016	27

Page 1